UNITED THERAPEUTICS Corp - Common Stock (UTHR)
CUSIP: 91307C102
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 43,898,805
- Total 13F shares
- 41,360,375
- Share change
- -551,967
- Total reported value
- $3,298,822,179
- Put/Call ratio
- 92%
- Price per share
- $79.75
- Number of holders
- 293
- Value change
- -$43,165,509
- Number of buys
- 114
- Number of sells
- 178
Quarterly Holders Quick Answers
What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 91307C102:
Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
4,492,667
|
$350,697,000 | — | 30 Jun 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.1%
|
3,988,515
|
$311,343,000 | — | 30 Jun 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
6.9%
|
3,040,978
|
$237,379,000 | — | 30 Jun 2019 | |
| FMR LLC |
13F
|
Company |
5.6%
|
2,476,276
|
$193,298,000 | — | 30 Jun 2019 | |
| STATE STREET CORP |
13F
|
Company |
4.2%
|
1,837,917
|
$143,468,000 | — | 30 Jun 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.8%
|
1,661,839
|
$129,723,000 | — | 30 Jun 2019 | |
| Palo Alto Investors LP |
13F
|
Company |
3.5%
|
1,552,792
|
$121,211,000 | — | 30 Jun 2019 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
2.8%
|
1,210,154
|
$94,465,000 | — | 30 Jun 2019 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.6%
|
1,131,144
|
$87,618,000 | — | 30 Jun 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
2.1%
|
913,121
|
$71,275,000 | — | 30 Jun 2019 | |
| THOMPSON SIEGEL & WALMSLEY LLC |
13F
|
Company |
2%
|
865,204
|
$67,537,000 | — | 30 Jun 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
849,616
|
$66,319,000 | — | 30 Jun 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.9%
|
833,348
|
$65,051,000 | — | 30 Jun 2019 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.8%
|
785,460
|
$61,313,000 | — | 30 Jun 2019 | |
| Consonance Capital Management LP |
13F
|
Company |
1.8%
|
770,769
|
$60,166,000 | — | 30 Jun 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.6%
|
687,901
|
$53,698,000 | — | 30 Jun 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.5%
|
671,595
|
$52,425,000 | — | 30 Jun 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
666,774
|
$52,048,000 | — | 30 Jun 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.3%
|
557,531
|
$43,522,000 | — | 30 Jun 2019 | |
| Krensavage Asset Management, LLC |
13F
|
Company |
1.3%
|
550,299
|
$42,956,000 | — | 30 Jun 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
517,318
|
$40,381,000 | — | 30 Jun 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.1%
|
500,803
|
$39,093,000 | — | 30 Jun 2019 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
498,010
|
$38,875,000 | — | 30 Jun 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1%
|
459,440
|
$35,864,000 | — | 30 Jun 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
456,133
|
$35,605,000 | — | 30 Jun 2019 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.9%
|
393,536
|
$30,719,000 | — | 30 Jun 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.87%
|
380,055
|
$29,663,000 | — | 30 Jun 2019 | |
| Camber Capital Management LP |
13F
|
Company |
0.84%
|
367,529
|
$28,689,000 | — | 30 Jun 2019 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.74%
|
324,000
|
$25,291,000 | — | 30 Jun 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.51%
|
224,483
|
$17,524,000 | — | 30 Jun 2019 | |
| BRANDES INVESTMENT PARTNERS, LP |
13F
|
Company |
0.51%
|
222,150
|
$17,342,000 | — | 30 Jun 2019 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.49%
|
213,752
|
$16,685,000 | — | 30 Jun 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.45%
|
198,441
|
$15,490,000 | — | 30 Jun 2019 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.44%
|
193,129
|
$15,076,000 | — | 30 Jun 2019 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.44%
|
192,075
|
$14,993,000 | — | 30 Jun 2019 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.41%
|
179,524
|
$13,852,000 | — | 30 Jun 2019 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.35%
|
155,212
|
$12,116,000 | — | 30 Jun 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.35%
|
151,452
|
$11,823,000 | — | 30 Jun 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.34%
|
150,000
|
$11,709,000 | — | 30 Jun 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.34%
|
149,219
|
$11,647,000 | — | 30 Jun 2019 | |
| PEAK6 Investments LLC |
13F
|
Company |
0.33%
|
143,851
|
$11,229,000 | — | 30 Jun 2019 | |
| Greylin Investment Management, Inc |
13F
|
Company |
0.32%
|
138,978
|
$10,849,000 | — | 30 Jun 2019 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.29%
|
127,167
|
$9,927,000 | — | 30 Jun 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.29%
|
126,208
|
$9,852,000 | — | 30 Jun 2019 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.27%
|
118,980
|
$9,288,000 | — | 30 Jun 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.26%
|
115,153
|
$8,989,000 | — | 30 Jun 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0.26%
|
113,646
|
$8,871,000 | — | 30 Jun 2019 | |
| CITIGROUP INC |
13F
|
Company |
0.24%
|
107,336
|
$8,379,000 | — | 30 Jun 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.24%
|
105,467
|
$8,233,000 | — | 30 Jun 2019 | |
| Railway Pension Investments Ltd |
13F
|
Company |
0.24%
|
105,283
|
$8,218,000 | — | 30 Jun 2019 |
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2019
As of 30 Sep 2019,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
293 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,360,375 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, Palo Alto Investors LP, Consonance Capital Management LP, and D. E. Shaw & Co., Inc..
This page lists
293
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
310
Q3 2019 holders
293
Holder diff
-17
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.